Circ Res 116:15611578 Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I et al (1997) Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in rats
Gastrointestinal mucosal research BPC-157 is strongly linked to gastric and gastrointestinal research
Both are not approved for human or veterinary use
In addition, it has been shown that SAG pretreatment significantly prevents CCl4-induced cytotoxicity, is protective in restoring mitochondrial autophagy, and attenuates fibrosis, collagen deposition, hepatocellular damage and organ dysfunction
Adverse reactions to any substance can also be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk
This guide walks through every step